Clinical Trials Sponsored by Seagen Inc.

Total 36144 results

Emory University
National Cancer Institute (NCI); Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen...

Recruiting

Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology

Stage III Bladder Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Bladder Adenocarcinoma | Bladder Squamous Cell Carcinoma | Metastatic Bladder Carcinoma | Urachal Adenocarcinoma | Locally Advanced Bladder Carcinoma | Malignant Renal Pelvis Neoplasm | Malignant Ureter Neoplasm | Malignant Urethral Neoplasm and other conditions

United States
Memorial Sloan Kettering Cancer Center
Seagen Inc.; Hôpitaux Universitaires Henri Mondor, France

Completed

Brentuximab Vedotin (SGN-35) in Transplant Eligible Patients With Relapsed or Refractory Hodgkin Lymphoma

Hodgkin's Lymphoma

United States
Northwestern University
National Cancer Institute (NCI); Merck Sharp & Dohme LLC; Seagen Inc.

Withdrawn

Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma

Recurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated T-Cell Lymphoma | Recurrent Follicular T-Cell Lymphoma | Recurrent Hepatosplenic T-Cell Lymphoma | Recurrent... and other conditions

United States
Seagen Inc.
National Cancer Institute (NCI); Academic and Community Cancer Research United

Completed

Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer

Metastatic Colorectal Adenocarcinoma

United States, Spain, Belgium, France, Italy
Reva Basho
Merck Sharp & Dohme LLC; Seagen Inc.

Withdrawn

TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases (TOPAZ)

Breast Cancer | HER2-positive Breast Cancer | Brain Metastases | CNS Disease

United States
Sumagen

Completed

Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients

HIV Infections

United States
Icagen

Completed

Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma

Exercise Induced Asthma

United States
Icagen

Completed

Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects

Atopic Asthma

United Kingdom
University of British Columbia
NexGen Hearing Inc.

Completed

Examining the Impact of Physician Influence on Hearing Aid User Satisfaction and Retention

Hearing Loss

Canada
Nexgen Pharma, Inc
Pharmaceutical Research Unit, Jordan

Completed

Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical Study (COGUSS)

Cough

Jordan
University Hospital, Geneva
QIAGEN Gaithersburg, Inc; Hologic, Inc.; Pregnolia AC

Completed

Prediction of Spontaneous Onset of Labor at Term (PREDICT)

Labor Onset | Labor, Induced | Labor, Obstetric | Predictive Model

Switzerland
Northwestern University
Sage Products, Inc.

Completed

Pre-operative Preparation Using 2% Chlorhexidine Cloth For Shoulder Surgery

Post-operative Surgical Site Infections

United States
Assistance Publique - Hôpitaux de Paris
QIAGEN Gaithersburg, Inc

Recruiting

Impact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community-acquired Pneumonia in the Emergency Room (PROMCAP)

Community-acquired Pneumonia

France
Sidney Kimmel Comprehensive Cancer Center at Johns...
Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen Inc.

Not yet recruiting

Renal Retention in High Grade Upper Tract Urothelial Cancer

Bladder Cancer | Urothelial Carcinoma Bladder | High Grade Urothelial Carcinoma

United States
Eikon Therapeutics
Seven and Eight Biopharmaceuticals Inc

Active, not recruiting

BDB001-102: Open Label Dose Escalation of BDB001 in Combination w Atezolizumab

Tumor, Solid

United States
Karsten Königstein
University of Basel; QIAGEN Gaithersburg, Inc

Completed

VascuFit: Exercise and Vascular Aging (VascuFit)

Aerobic Exercise | Endothelial Function | Middle-aged Adults Sedentary, Elevated CV-risk)

Switzerland
University of Bergen
Helse-Bergen HF

Completed

Transcranial Brain Stimulation and Its Underlying Neural Mechanisms as a Novel Treatment for Auditory Hallucinations

Psychotic Disorders

Norway
Bergen University College
University of Bergen

Unknown

The Effect of an Evidence-based Physiotherapy Regimen for Patients With Rotator Cuff Tendinopathy

Tendinopathy | Shoulder Impingement Syndrome | Shoulder Pain | Subacromial Impingement

Norway
Memgen, LLC
University of California, San Diego; The Leukemia and Lymphoma Society

Completed

A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLL

Chronic Lymphocytic Leukemia

United States
Eikon Therapeutics
Seven and Eight Biopharmaceuticals Inc

Completed

BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid Tumors

Tumor, Solid

United States
Bergen University College
Helse-Bergen HF

Completed

Evaluation of Training in De-escalation

De-escalation Skills

Norway
Oxagen Ltd

Completed

OC000459 Dose Finding Study in Hay Fever Sufferers.

Allergic Rhinitis

Austria
Canadian Cancer Trials Group
Bristol-Myers Squibb; Pfizer; Hoffmann-La Roche; AstraZeneca; Seagen Inc.

Recruiting

Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) (CAPTUR)

Lymphoma, Non-Hodgkin | Multiple Myeloma | Advanced Solid Tumors

Canada
Oxagen Ltd

Completed

A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis

Allergic Rhinitis

Austria
Oxagen Ltd

Completed

OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma

Mild to Moderate Persistent Asthma

Bulgaria, Russian Federation, Hungary, Romania, Ukraine, Poland
Oxagen Ltd

Completed

Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4

Healthy Volunteers

United Kingdom
Oxagen Ltd

Completed

Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects

Asthma

Russian Federation
Meagan Medical

Terminated

Pilot Study to Examine the Feasibility of the Dynamic Interferential Spinal Cord Stimulation System™ (DISCSS™)

Back Pain

United States
Stragen France

Completed

First-In-Human PainCart Study for STR-324

Pain

Netherlands
Slaven Falamić

Completed

Pharmacist Interventions in Rural Elderly Warfarin Patients

Hemorrhage | Thrombosis | Atrial Fibrillation | Cardiac Failure
Oxagen Ltd

Completed

Proof of Concept Study of OC000459 in Eosinophilic Esophagitis

Eosinophilic Esophagitis

Switzerland
University of Rochester
Sage Products, Inc.

Completed

Eliminate Risk of Cardiac Surgical Site Events (ERASE)

Surgical Site Infections

United States
University of Calgary
Sage Products, Inc.

Completed

Implementation and Evaluation of Revised Protocols for Oral Hygiene for Mechanically Ventilated Patients

Oral Hygiene | Ventilator Associated Pneumonia

Canada
Johns Hopkins University
Sage Products, Inc.

Completed

Study of Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit

Nosocomial Infections

United States
Maimónides Biomedical Research Institute of Córdoba
QIAGEN Gaithersburg, Inc

Unknown

Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients (CYTHEMAT)

Cytomegalovirus Infection | HSCT

Spain
Institut für Pneumologie Hagen Ambrock eV
PneumRx, Inc.

Completed

Improvement of Sleep Quality by RePneu® Coils in Advanced Pulmonary Emphysema

Emphysema | COPD

Germany
National Institute of Allergy and Infectious Diseases...
PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Seagen...

Completed

Brentuximab Vedotin for Systemic Sclerosis (BRAVOS)

Diffuse Cutaneous Systemic Sclerosis | Scleroderma | dcSSc

United States
Helse-Bergen HF

Active, not recruiting

Comparison of an Old Versus a New Total Knee Replacement

Osteoarthritis Knee

Norway
University of Bergen

Completed

Low-level Laser Therapy in Distal Radius Fractures

Colles' Fracture

Norway
University of Bergen

Completed

Inflammatory Targeted Laser Treatment of Knee Osteoarthritis

Knee Osteoarthritis

Norway
University of Bergen

Withdrawn

Priority Setting and Waiting Time Decision in the Referral Process, How and by Whom? (Priority)

Communication

Norway
University of Bergen

Completed

Postprandial Effects of Functional Bread

Postprandial Hyperglycemia

Norway
University of Bergen

Completed

Risk Assessment of Type 2 Diabetes in Pharmacies

Type2 Diabetes
University of Bergen

Completed

The Effects of a Blue Monochromatic Light Intervention on Evening-type Individuals' Sleep and Circadian Rhythms

Sleep | Circadian Rhythm Sleep Disorder, Delayed Sleep Phase

Norway
University of Bergen

Completed

Cognitive Behavioural Treatment of Intra-oral Injection-phobia in 10-16 Year Old Children and Adolescents

Dental Anxiety

Norway
University of Bergen

Completed

Randomized Controlled Trial of a Self-help Book for Insomnia in Patients With Co-morbid OSA and Insomnia

Insomnia | Sleep Apnea

Norway
University of Bergen

Completed

Self-management of Anticoagulation Treatment

Atrial Fibrillation | Venous Thromboembolism | Artificial Heart Valve
Centre Hospitalier d'Agen

Unknown

Multicenter National Randomized Controlled Open Label Study Assessing Interest of Non Invasive Ventilation in out-of Hospital Setting During Acute Respiratory Failure in Chronic Obstructive Pulmonary Disease Patients. VeNIS BPCO (VeNIS BPCO)

Acute Respiratory Failure | Exacerbation of COPD | Non Invasive Positive Pressure Ventilation | Out of Hospital Setting
Bergen Knee Group

Completed

Clinical Follow-up After ACL Reconstruction (Howell)

Injury of Anterior Cruciate Ligament | Deficiency of Anterior Cruciate Ligament

Norway
University of Bergen

Completed

Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting (BPP)

Psychotic Disorders

Norway

Clinical Trials Sponsored by Seagen Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations